
<p class="wp-block-paragraph">President Trump’s upcoming term is currently in the team-building phase with nominations of key officials in place and awaiting confirmation hearings starting next month. To fight his presidency, the anti-American establishment is preparing itself as well. And one of its most effective weapons in this fight is the pharmaceutical industry.</p>



<p class="wp-block-paragraph">The manufactured pandemic of 2020 was executed by the swamp under Trump’s nose as he was preparing for his re-election campaign. The corrupt medical-pharmaceutical alliance that virtually runs the federal health agencies successfully conned Trump into fast-tracking useless and dangerous vaccines while many states, mostly Democrat-controlled, took away people’s basic freedoms. The situation was mirrored abroad, in some cases worse than America.</p>



<p class="wp-block-paragraph">Four years later, Trump has reclaimed the presidency. But the choices he has made for holding the key federal health offices have sent a mixed message to the MAGA base that has piled big hopes for accountability over the past four years. On one hand, the nomination of Robert Francis Kennedy (RFK) Jr. to lead the Health and Human Services (HHS) has won Trump a great deal of support since RFK Jr. has a track record of fighting for medical freedom and exposing the dirty business of big pharma. On the other hand, naming a vaccine pusher and pro-censorship doctor – Janette Nesheiwat – as the next Surgeon General has left many conservatives deeply disappointed.</p>



<p class="wp-block-paragraph">On December 13, a little known conservative group Conservatives for Lower Health Care Costs raised the alarm over the joint effort of the political left and big pharma to give the pharmaceuticals a $32 billion payout in the year-end spending deal. The post cited Donald Trump Jr. and other conservatives to condemn this effort as a scheme to whip Americans with further increases in healthcare costs.</p>



<p class="wp-block-paragraph">Based on the aforementioned post, <em>Breitbart</em> noted (December 15) that this bill would undermine President Trump’s commitment to take on big pharma. The story wrote:</p>



<p class="wp-block-paragraph"><em>In November, Americans voted for President Trump because they think he’ll take on Big Pharma, but instead of that they’ll now see a massive Big Pharma windfall AND hiked health care costs, undoubtedly leaving Americans to think Trump didn’t keep his promise.</em></p>



<p class="wp-block-paragraph">On Wednesday (December 18), <em>Fortune</em> published a story about Trump criticizing pharmacy benefit managers as those responsible for raising the prices of medications. The story wrote that President Trump’s criticism had an immediate negative impact on health insurers’ stocks:</p>



<p class="wp-block-paragraph"><em>President-elect Donald Trump’s continued criticism of pharmacy benefit managers has sent health insurers’ stocks slumping.</em></p>



<p class="wp-block-paragraph">But does criticism suffice in holding the wrongdoers accountable? David Gornoski brought up the question of accountability and justice in the coming Trump presidency for the oppressive and tyrannical policies of the medical-pharmaceutical establishment carried out via the federal health agencies and channels of information. Dr. Peter McCullough, an outspoken critic of the government-pharma alliance during the COVID-19 emergency years and beyond, did not sound very hopeful as he answered the question.</p>



<p class="wp-block-paragraph"><a href="https://www.bitchute.com/video/A4OcGTkhpXHV">https://www.bitchute.com/video/A4OcGTkhpXHV</a></p>

Will the Swamp Strike at Trump Using Big Pharma as a Sword?
